Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment

European Journal of Immunology
Françoise LepaultC Boitard

Abstract

The process of mononuclear cell extravasation from the blood into the islets of Langerhans in nonobese diabetic (NOD) mice is dependent on the expression of a set of molecules, most of which remain to be defined. The observation that vascular addressins are expressed in inflamed islets raises the issue of the involvement of one of their ligands, L-selectin, in the pathogenesis of autoimmune diabetes. Treatment of NOD females with Mel-14, an antibody specific for L-selectin, reduced the spontaneous development of both insulitis and diabetes. Pretreatment of diabetic donors with Mel-14 decreased the capacity of their splenocytes to transfer the disease. However, the treatment of recipients had no effect on the transfer of diabetes by untreated diabetogenic splenocytes. To reconcile these apparently conflicting results, we fractionated spleen T cells from diabetic mice according to L-selectin expression. Diabetogenic cells were found only in the L-selectin subpopulation. Thus, diabetogenic cells in adult mice share phenotypic characteristics with activated/memory cells, and enter the pancreas using L-selectin-independent migratory pathways.

References

Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·L J Wysocki, V L Sato
Apr 1, 1992·European Journal of Immunology·C R MackayW R Hein
Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·U H von AndrianE C Butcher
Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A SethP S Nagarkatti
Jan 1, 1980·Jikken dobutsu. Experimental animals·S MakinoY Tochino
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·X D YangH O McDevitt
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·A Varki
Dec 1, 1994·The Journal of Experimental Medicine·L M BradleyS L Swain
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·X D YangH O McDevitt
Dec 1, 1993·Diabetes·F LepaultM C Gagnerault
May 1, 1993·The Journal of Experimental Medicine·C MohanS K Datta
May 1, 1993·Immunology Today·P PozzilliP E Beales

❮ Previous
Next ❯

Citations

Apr 21, 1999·Clinical and Experimental Immunology·E SavilahtiH K Akerblom
Jul 6, 2001·Scandinavian Journal of Immunology·J F Bach
Jun 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Cristina PenarandaHans Dooms
Nov 11, 2005·American Journal of Therapeutics·Nick Giannoukakis, Massimo Trucco
Dec 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Marie-Alexandra AlyanakianJean-François Bach
Sep 29, 2005·Expert Opinion on Biological Therapy·Lucienne Chatenoud, Jean-François Bach
Nov 28, 2012·La Presse médicale·Christian Boitard
Aug 22, 2000·Immunopharmacology and Immunotoxicology·J C Flynn, M F McInerney
Jul 23, 2005·International Reviews of Immunology·Lucienne Chatenoud, Jean-François Bach
Apr 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A M YamamotoL Chatenoud
Feb 26, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Danielle M TartarHabib Zaghouani
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C Dobbs, K Haskins
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·F Lepault, M C Gagnerault
Oct 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marie-Claude GagneraultFrançoise Lepault
Mar 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Randall H FriedlineRoland Tisch
Sep 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Deepak YadavNora Sarvetnick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.